NCT03934684 Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE4
NCT03931642 BLINAtumomab After R-CHOP Debulking Therapy for Patients With Richter Transformation Status COMPLETED Phase PHASE2
NCT03930186 A Phase 3B, Open-label, Single-arm Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy Status COMPLETED Phase PHASE3
NCT03927157 Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma Status COMPLETED Phase PHASE3
NCT03927144 Study of Sustained Benefit of AMG334 in Adult Episodic Migraine Patients Status COMPLETED Phase PHASE4
NCT03925532 Denosumab in Treating Patients With Bone Loss Due to Donor Stem Cell Transplant Status COMPLETED Phase PHASE2
NCT03912337 Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine Status TERMINATED Phase PHASE4
NCT03904069 Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML Status WITHDRAWN Phase PHASE1
NCT03872401 Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Status COMPLETED Phase PHASE3
NCT03861533 GOAL International QuERI - Protocol CHRC 2019 GOAL INTERNATIONAL Status COMPLETED Phase N/A
NCT03859427 A Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination With Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma Status COMPLETED Phase PHASE3
NCT03852472 Evaluation of Safety and Efficacy of Avacopan in Subjects With Moderate to Severe Hidradenitis Suppurativa (AURORA) Status COMPLETED Phase PHASE2
NCT03851263 Multislice Computed Tomography Assessment of PCSK9 Inhibition on Coronary Perfusion Status WITHDRAWN Phase PHASE4
NCT03848052 Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC) Status RECRUITING Phase N/A
NCT03836053 Assessment of AMG 420 in Subjects With Relapsed and/or Refractory Multiple Myeloma Status TERMINATED Phase PHASE1
NCT03836040 Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03832998 Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine Status COMPLETED Phase PHASE3
NCT03829046 The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease Status COMPLETED Phase PHASE4